2Alencar RC, Cobas RA, Gomes MB. Allergic reaction related to ramipril use: a case report [J~. Diabetol Metab Syndr, 2010, 2: 4. DOI: 10.1186/1758-5996-2-4.
3Ozturk G, Turk BG, Senturk B, et al. Exanthematous drug eruption due to valsartan [J]. Cutan Ocul Toxicol, 2012, 31 (4): 335-337. DOI:10.3109/15569527.2011.647179.
4Fessa C, Lim P, Kossard S, et al. Lichen planus-like drug eruptions due to beta-blockers: a case report and literature review [J]. Am J Clin Dermatol, 2012, 13 (6): 417-421. DOI: 10.2165/11634590- 000000000-00000.
5Joly P, Benoit-Corven C, Baricault S, et al. Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: resuhs from a case-control study [J]. J Invest Dermatol, 2007, 127( 12): 2766-2771.
6Rasmussen E, Mey K, Bygum A. Angiotensin-converting enzyme inhibitor-induced angioedema:a dangerous new epidemic [J~. Acta Derm Venereol, 2014, 94 (3): 260-264. DOI: 10.2340/00015555- 1760.
7Powell R J, Leech SC, Till S, et al. BSACI guideline for the management of chronic urticaria and angioedema [J]. Clin Exp Allergy, 2015, 45(3): 547-565. DOI: 10.1111/cea.12494.
8Cilia LCA, Carter AM, Rice GI, et al. A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema [J~. Hum Mutat, 2011, 32( 11 ): 1326-1331. DOI: 10.1002/humu.21579.
9Basavaraj KH, Ashok NM, Rashmi R, et al. The role of drugs in the induction and/or exacerbation of psoriasis [ J ~. Int J Dermatol, 2010, 49(12): 1351-1361. DOI: 10.1111/j.1365-4632.2010.04570.x.
10Gin A, Gin D, Sinclair R. Metoprolol-induced psoriatic nail disease [ J ]. Australas J Dermatol, 2013, 54 ( 1 ): 59-60. DOI: 10.1111/j. 1440-0960.2012.00916 .x.
